A systematic review and meta-analysis of 40 studies of antibody testing for novel coronavirus (SARS-CoV-2) has found “major weaknesses” in the evidence base for serological tests. The evidence does not support the continued use of existing point-of-care serological tests for COVID-19. Serological tests to detect antibodies against novel coronavirus (SARS-CoV-2) could improve diagnosis of COVID-19 … Continue reading Meta-analysis does not support continued use of point-of-care serological tests for COVID-19
Antibody test
After being in denial, India takes a decisive step to confirm community spread
After displaying extreme reluctance to admit community transmission despite having over 67,000 cases and the nature of the virus spread, India has finally decided to confirm community spread by testing 30,000 people in 75 hotspot districts. As early as March 28, the Health Ministry acknowledged that there was “limited community transmission” of novel coronavirus (SARS-CoV-2) in … Continue reading After being in denial, India takes a decisive step to confirm community spread
NIV develops ELISA test to detect coronavirus antibodies
In a first, NIV Pune has developed an ELISA test to detect IgG antibodies that are developed in response to infection by novel coronavirus. The ELISA test, to be manufactured by Zydus Cadila, will be used for testing the blood samples of 30,000 people in 75 hotspot districts. The Pune-based National Institute of Virology has … Continue reading NIV develops ELISA test to detect coronavirus antibodies
Science Chronicle 